![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Novo Nordisk Divests Ferrosan Shareholding
Novo Nordisk Divests Ferrosan Shareholding
Diabetes care leader Novo Nordisk has completed a definitive agreement to sell its entire shareholding in Ferrosan to a holding company, making the Altor 2003 Fund the new majority shareholder in the Ferrosan group. The purchasing holding company is controlled by the Altor 2003 Fund and pre-existing shareholder Idosan.
Pharmaceutical Business Review (http://www.pharmaceutical-business-review.com/article_news.asp?guid=193996EF-4814-46F9-B764-37B33DB71320)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct